Study update

27

Apr, 2022

The D3 study has screened the first 2 children

 

Great day for the D3 study, today. The first 2 children have been screened for the study at the Prapokklao Hospital in Thailand. Thanks to the MRC CTU and the PHPT team to coordinate this effort. Through D3, we aim to assess whether the combination of DTG/3TC is just as effective as the standard of care in terms of virological suppression in children and adolescents. The trial will also compare the toxicity, adherence, tolerability, acceptability and quality of life in participants of this combination versus that of the standard of […]

READ MORE

26

Apr, 2022

GARDP study reveals that babies are increasingly dying of neonatal sepsis caused by drug-resistant bacterial infections

Tags: ,

Geneva, 26 April 2022 – A large study focusing on newborn babies with clinically diagnosed sepsis has revealed the impact of antibiotic resistance on neonatal sepsis, a major cause of death in newborns. At the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), the Global Antibiotic Research and Development Partnership (GARDP) has released a second wave of findings from its study on the outcomes of more than 3,200 newborns with neonatal sepsis, a life-threatening bloodstream infection that affects up to 3 million babies a year. The study shows that […]

READ MORE

26

Apr, 2022

GARDP study reveals that babies are increasingly dying of neonatal sepsis caused by drug-resistant bacterial infections

Tags: ,

Geneva, 26 April 2022 – A large study focusing on newborn babies with clinically diagnosed sepsis has revealed the impact of antibiotic resistance on neonatal sepsis, a major cause of death in newborns. At the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), the Global Antibiotic Research and Development Partnership (GARDP) has released a second wave of findings from its study on the outcomes of more than 3,200 newborns with neonatal sepsis, a life-threatening bloodstream infection that affects up to 3 million babies a year. The study shows that […]

READ MORE

26

Apr, 2022

Uno studio di GARDP rivela che i neonati muoiono sempre più frequentemente per sepsi neonatale causata da infezioni batteriche resistenti ai farmaci

Tags: ,

Ginevra, 26 Aprile 2022 – Un importante studio sui neonati ha rivelato l’impatto della resistenza agli antibiotici sulla sepsi neonatale, una delle principali cause di morte tra i neonati. Al Congresso europeo di microbiologia clinica e malattie infettive (ECCMID), GARDP – un partenariato internazionale per la ricerca e lo sviluppo di antibiotici (Global Antibiotic Research and Development Partnership) – ha presentato una serie di risultati provenienti da uno studio condotto su oltre 3.200 neonati con sepsi neonatale, un’infezione potenzialmente mortale. Lo studio ha rivelato che il numero di bambini che […]

READ MORE

25

Apr, 2022

PentaTr@ining 2022: online course kicks off!

Tags:

Our interactive course PentaTr@ining 2022: ‘HIV & other Congenital Infections’ kicks off today! The innovative online programme comprises 6 interactive and in-depth training modules, a wide variety of real-life clinical cases for discussion, live ‘Q&A’ webinars and dedicated tutoring from our expert international teaching faculty. To consolidate the online training, the course will conclude with a face-to-face workshop at the historic venue of Pontificia Università Urbaniana in Rome, Italy on 28-30 September. The residential course promises an exciting 3-day programme of topical presentations, small group case discussions, and fun quizzes! The key training objective […]

READ MORE
NEWSLETTER

We would like to update you on our recent activities